Jason Hsu

124 posts

Jason Hsu

@JasonHsuMD

Co-Director of Retina Research @Wills_Eye | Retina Surgeon @MidAtl_Retina | Professor @JeffersonUniv

Philadelphia, PA Katılım Ekim 2019

105 Takip Edilen558 Takipçiler

Jason Hsu@JasonHsuMD·13 Mar

Excited to announce our analysis of DRCR Protocol AC (Avastin first vs. Eylea only for Diabetic Macular Edema). Eylea only subjects achieved absence of DME and very good vision ~3 months sooner, suggesting a downside to step therapy with Avastin first. authors.elsevier.com/a/1mlm%7E8nJeI…

English

Jason Hsu@JasonHsuMD·14 Eyl

In patients with high genetic risk for #AMD progression, healthy lifestyle behaviors could still lower risk of advanced AMD. 55-60% of development of advanced AMD is due to these lifestyle factors. Presented by Joanna Seddon at #RSLisbon2024 @RetinaSociety

English

227

Jason Hsu@JasonHsuMD·14 Eyl

Use of levodopa was associated with 32% reduced development of new-onset geographic atrophy. It may dilate choroidal vasculature or reduce oxidative stress. However difficult to determine effect of Parkinson’s. Presented by Jeremy Lavine at #RSLisbon2024 @RetinaSociety

English

134

Jason Hsu@JasonHsuMD·14 Eyl

Metformin use shown to be associated with lower risk of new #AMD and dry AMD. Presentation at #RSLisbon2024 by Dmitra Skondra shows association between metformin use and 47% reduced odds of geographic atrophy in patients without diabetes @RetinaSociety

English

241

Jason Hsu@JasonHsuMD·14 Eyl

Faricimab associated with greater reductions in pigment epithelial detachment. Better early drying of fluid associated with greater likelihood of extension to 16 weeks. Over 50% could have been extended to 20 weeks. Terrific talks at #RSLisbon2023 @RetinaSociety @TheIVIpodcast

English

295

Jason Hsu@JasonHsuMD·13 Eyl

Phase 2 subretinal gene therapy of ABBV-RGX-314 in previously treated wet AMD showed good tolerance with few cases of inflammation responsive to steroid drops + stable vision and edema with over 70% injection free over 6 mos. @allenho #RSLisbon2024 @RetinaSociety @Wills_Eye

English

1.8K

Jason Hsu@JasonHsuMD·13 Eyl

Study of real world use of Eylea HD by >300 retina docs showed mean extension of 14 days by the 4th EHD injection compared to interval prior to being switched. Low rates of adverse events. Presented by @NJRetinaDoc at #RSLisbon2024 @RetinaSociety @MidAtl_Retina @Wills_Eye

English

716

Jason Hsu@JasonHsuMD·12 Eyl

Fascinating study on use of intravitreal methotrexate and rituximab for treatment of bilateral diffuse uveal melanocytic proliferation presented by Jasmine Francis at #RSLisbon2024, showing potential for long term vision improvement and preservation. @RetinaSociety

English

Jason Hsu@JasonHsuMD·12 Eyl

Genome wide association study found central serous retinopathy was associated with vascular endothelial protein tyrosine phosphatase which is modulated by faricimab. @LizzyRossin presented a small case series showing fluid resolution with faricimab injections #RSLisbon2024

English

Jason Hsu@JasonHsuMD·12 Eyl

Smaller ellipsoid zone lesion size, younger age, and lack of foveal involvement portended a greater reduction in disease progression with NT-501 (encapsulated cell technology) for macular telangiectasis type 2. Presented by Anthony Capone at #RSLisbon2024 @RetinaSociety

English

164

Jason Hsu@JasonHsuMD·12 Eyl

Very interesting study by @GlennYiuMD at #RSLisbon2024 about modifying rod photoreceptors to be more cone-like in order to mitigate retinal pigment epithelial atrophy in a geographic atrophy animal model. @RetinaSociety

English

Jason Hsu@JasonHsuMD·12 Eyl

Phase 2 trial of bel-sar for choroidal melanoma showed 80% local tumor control rate with 90% having vision preservation and a very good safety profile presented by Ivana Kim at #RSLisbon2024 @RetinaSociety

English

125

Jason Hsu@JasonHsuMD·12 Eyl

Outstanding talk by @eyeamprithvi at #RSLisbon2024 on his study of using aqueous humor to determine metastatic risk potential of uveal melanoma @RetinaSociety

English

Jason Hsu@JasonHsuMD·12 Eyl

Fantastic diabetic retinopathy session at #RSLisbon2024 with three great talks focusing on health disparities and inequities in diabetic retinopathy by @DrKNwan, Brian VanderBeek, and Anjali Shah @RetinaSociety

English

191

Jason Hsu@JasonHsuMD·12 Eyl

Concept of suprachoroidal injection of viscoelastic in rhegmatgenous retina detachment to create a temporary buckle without need for gas or positioning. Terrific presentation of 6 cases by Rajeev Muni at #RSLisbon2024 @RetinaSociety

English

Jason Hsu retweetledi

Ophthalmology@AAOjournal·22 Tem

New #OphthalmologyJournal #Podcast! @iDrFeng interviews @momenaeib & @JasonHsuMD on the incidence, timing, risk factors, and outcomes of recurrent retinal detachment after phacoemulsification aaojournal.org/audio-do/recur…

English

977

Jason Hsu@JasonHsuMD·11 May

Thanks @SArepalliMD @RetinalPhys for highlighting our study which found that cumulative endophthalmitis risk seems to decrease with greater number of intravitreal injections. Check out the article for some of our hypotheses

Retinal Physician@RetinalPhys

Exploring Risk of #Endophthalmitis With Intravitreal Injections: A recent report assessed the cumulative risk of endophthalmitis. By Sruthi Arepalli, MD retinalphysician.com/issues/2024/ap… #uveitis #ophthalmology

English

351

Jason Hsu@JasonHsuMD·11 Nis

Enjoyed this opportunity to better understand how #MacularDegeneration impacts our patients and how what we do as retina specialists can help improve quality of life

Med Learning Group@MLG_CME

Experience a unique CME Activity w/ @JasonHsuMD that takes you on a patient journey with nAMD. Gain insights into various therapies and discover the latest technological updates. 👉ow.ly/CXrH50QX8PV #CME #MedEd #Ophthalmology #MacularDegeneration #optometry

English

248

Jason Hsu@JasonHsuMD·11 Nis

The risk of post-injection endophthalmitis doesn’t increase linearly as patients receive more injections but is higher early on and lower later in the course of treatment. Check out our theories: authors.elsevier.com/a/1iud3amCtQzew @RIsrailevichMD @HanaMansourMD @YoshiYonekawaMD @Wills_Eye

English

920

Jason Hsu retweetledi

Elliott Sohn MD@ElliottSohnMD·12 Oca

📣Attention Retina docs, your input is needed! @asrsdocs has proposed a Focused Practice Designation in Medical/Surgical Retina to the ABO.🚀 First time a subspecialty could receive such designation in #ophthalmology. Public comment open til 1/26/24. abms.org/cocert-invites… 🌐👁️

English

772

Keşfet

@RetinaSociety @TheIVIpodcast @allenho @Wills_Eye @NJRetinaDoc @MidAtl_Retina @LizzyRossin @GlennYiuMD